News | June 26, 2025
Philogen withdraws marketing authorization application for Nidlegy in EU
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare
Ibara will drive AI-powered clinical research innovation
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Subscribe To Our Newsletter & Stay Updated
